INIFY Laboratories AB (OSL: INIFY)
Norway
· Delayed Price · Currency is NOK 4.500
-0.320 (-6.64%)
At close: Jan 17, 2025
INIFY Laboratories AB Market Cap
INIFY Laboratories AB has a market cap or net worth of 203.57 million as of January 21, 2025. Its market cap has decreased by -65.91% in one year.
Market Cap
203.57M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.50
Market Cap Chart
Since June 20, 2022, INIFY Laboratories AB's market cap has decreased from 452.37M to 203.57M, a decrease of -55.00%. That is a compound annual growth rate of -26.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2025 | 203.57M | -10.00% |
| Dec 30, 2024 | 226.18M | -59.68% |
| Dec 29, 2023 | 560.94M | 72.20% |
| Dec 30, 2022 | 325.75M | -27.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nordhealth AS | 3.43B |
| Medistim ASA | 2.72B |
| Photocure ASA | 1.46B |
| Hofseth BioCare ASA | 1.20B |
| Vistin Pharma ASA | 1.00B |
| Nykode Therapeutics AS | 877.10M |
| ArcticZymes Technologies ASA | 715.00M |
| Omda AS | 680.06M |